HEATHER LEMBKE: Open Payments
NPI 1346894854 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,662 in 110 payments from 28 companies in 2025. Trend: 2023 $2,383 · 2024 $2,686 · 2025 $2,662
Food & beverage: $2,662
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $607 |
| Novo Nordisk Inc | 17 | $506 |
| PFIZER INC. | 19 | $285 |
| ABBVIE INC. | 13 | $220 |
| Lilly USA, LLC | 9 | $151 |
| Viatris Specialty LLC | 6 | $104 |
| Antares Pharma, Inc. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
Products named: FARXIGA, Wegovy, NURTEC ODT, Ozempic, JARDIANCE, YUPELRI, MOUNJARO, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
